Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Kathryn Maitland, Professor of Paediatric Tropical Infectious Diseases and based at the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya, was appointed Officer of the Order of the British Empire (OBE) in the Queen’s Birthday Honours

Kathryn Maitland

Kath Maitland is a paediatrician and infectious disease researcher who has dedicated her career to clinical research in critically ill children, including studying the impacts of malaria, bacterial sepsis and severe malnutrition with aim of improving mortality from these conditions

Based in East Africa for over 22 years, Professor Maitland’s work has largely focused on assessing and improving techniques used in the emergency care of children in resource-limited hospitals in sub-Saharan Africa.

Working across a network of sites in Kenya, Tanzania, Malawi and Uganda, her team has led clinical trials of a range of emergency interventions, which are helping to inform clinical decision making for treatments of patients. These include: whether transfusions with whole blood or red blood cell packs are most effective for children with anaemia; highlighting the risks of delivering intravenous fluids for children with severe febrile illness; and assessing the best way to administer oxygen to hospitalised children with pneumonia.

Her work with collaborators has led to improvement in patient outcomes, contributing to national and international guidelines for treating critically ill children, and ultimately helping to reduce child mortality.

Similar stories

VAnguard Launch

KWTRP hosted the launch of the VAnguard research project. The NIHR Funded Project Builds Knowledge-base on Factors Influencing Vaccine Impact among Communities in Kenya and Uganda. The project aims to strengthen collaborations between national and international stakeholders in the identification of social and biological factors that impair vaccine impact in African communities, to develop integrated strategies and recommendations to optimize vaccine impact, and to contribute to health equity in Africa. The launch concurrently took place in Kenya and Uganda from 28th – 30th November 2022.

Abhilasha Karkey, new OUCRU Nepal Director

OUCRU Nepal is pleased to announce that as of 01 October 2022, Dr Abhilasha Karkey will assume the role of Director.

Oxford University named world’s top university for the 7th consecutive year

The University of Oxford has been named the best university in the world for a record seventh consecutive year in the Times Higher Education (THE) World University Rankings 2023.

Four CTMGH researchers awarded full professorships

We are delighted to announce that four of our researchers have been awarded the title of Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine, University of Oxford.

Quality of care, health workers’ well-being and COVID-19

Nurses are central players in the provision of quality health care globally. Although neonatal units have not been at the epicenter of the current COVID-19 pandemic, challenges have also been raised for neonatal nurses. KWTRP share their COVID-19 related experiences and challenges, highlight strategies they used to manage the challenges and show how elements of the communication skills and emotional competence course helped them cope.

High prevalence of antibodies against COVID-19 within the general population: Evidence from Nairobi and Kilifi

By May 2022, 69% of individuals residing within the Kilifi Health and Demographic System (HDSS) and 91% residing within the Nairobi Urban HDSS had evidence of an immune response to COVID-19 resulting from natural infection and/or vaccination, i.e., anti-spike IgG antibodies.